Endocrine Consequences of Long-Term Intrathecal Administration of Opioids
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Intrathecal administration of opioids is a very efficient tool in the long-term control of intractable nonmalignant pain. However, despite the well known role of opioids in endocrine regulation, few data are available about possible effects on hypothalamic-pituitary function during this treatment. Seventy-three patients (29 men and 44 women; mean age, 49.2 ± 11.7 yr) receiving opioids intrathecally for nonmalignant pain were enrolled for extensive endocrine investigation. At the time of hormonal determination, the mean duration of opioid treatment was 26.6 ± 16.3 months; the mean daily dose of morphine was 4.8 ± 3.2 mg. The control group consisted of 20 patients (11 men and 9 women; mean age, 54.2 ± 14.0 yr) with a comparable pain syndrome but not treated with opioids. Decreased libido or impotency was present in 23 of 24 men receiving opioids. The serum testosterone level was below 9 nmol/L in 25 of 29 men and was significantly lower than that in the control group (P < 0.001). The free androgen index was below normal in 18 of 29 men and was significantly lower than that in the control group (P < 0.001). The serum LH level was less than 2 U/L in 20 of 29 men and was significantly lower than that in the control group (P < 0.001). Serum FSH was comparable in both groups. Decreased libido was present in 22 of 32 women receiving opioids. All 21 premenopausal females developed either amenorrhea or an irregular menstrual cycle, with ovulation in only 1. Serum LH, estradiol, and progesterone levels were lower in the opioid group. In all 18 postmenopausal females significantly decreased serum LH (P < 0.001) and FSH (P = 0.012) levels were found. The 24-h urinary free cortisol excretion was below 20 μg/day in 14 of 71 opioid patients and was significantly lower than that in the control group (P = 0.003). The peak cortisol response to insulin-induced hypoglycemia was below 180 μg/L in 9 of 61 opioid patients and was significantly lower than that in the nonopioid group (P = 0.002). The insulin-like growth factor I sd score was below −2 sd in 12 of 73 opioid patients and was significantly lower than that in the control group (P = 0.002). The peak GH response to hypoglycemia was below 3 μg/L in 9 of 62 subjects and was significantly lower than that in the control group (P = 0.010). Thyroid function tests and PRL levels were considered normal. No metabolic disturbances were recorded, apart from significantly decreased high density lipoprotein cholesterol levels (P = 0.041) and elevated total/high density lipoprotein cholesterol ratio (P = 0.008) in the opioid group compared to the control group. Supplementation with gonadal steroids improved sexual function in most patients. In conclusion, of all patients receiving intrathecal opioids, the large majority of men and all women developed hypogonadotropic hypogonadism, about 15% developed central hypocorticism, and about 15% developed GH deficiency. These findings suggest that further investigations are required to determine the need for systematic endocrine work-up in these patients and the necessity for substitutive therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A landmark study published 3 years later, investigating the effects of intrathecal opioids using the insulin tolerance test (ITT) (the gold standard for the diagnosis of secondary adrenal insufficiency), showed that 15% (9/61) of the patients on intrathecal opioids for nonmalignant pain had secondary adrenal insufficiency (74).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“These results suggest that up to 17% of the patients treated with intrathecal opioids may develop GH deficiency (74).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“Twelve opioid-treated patients (17%) had an IGF-I SD score below -2 SD, as opposed to no such case in the control group.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“Nine opioid-treated patients (15%) had a peak GH value consistent with severe GH deficiency (below 3 mcg/L), a finding not demonstrated in any control patient.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
In the citing paper
“The opioid-treated group had lower mean serum IGF-I (138.5 mcg/L ± 64.1) in comparison to the controls (162.0mcg/L ± 55.3; P = .045),as well as lower IGF-I SD score (-0.53 ± 1.45 and 0.57 ± 1.00; P = .002).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [74]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A quantitative approach to perceived health status: a validation study
Hunt, S. M., McKenna, S. P., McEwen, J., Backett, E. M., Williams, J., & Papp, E. (1980) · Journal of Epidemiology and Community Health · doi:10.1136/jech.34.4.281 · Cited by 924
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Side effects of intrathecal and epidural opioids
Chaney, M. A. (1995) · Canadian Journal of Anaesthesia · doi:10.1007/bf03011037 · Cited by 562
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
Diagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
The growth hormone deficiency syndrome in adults
Cuneo, R. C., Salomon, F., McGauley, G. A., & Sönksen, P. H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02347.x · Cited by 375
Winkelmüller, M., & Winkelmüller, W. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.85.3.0458 · Cited by 333
Intraspinal morphine for chronic pain: A retrospective, multicenter study
Paice, J. A., Penn, R. D., & Shott, S. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00099-2 · Cited by 302
The endocrinology of the opiates and opioid peptides
Morley, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90172-4 · Cited by 283
The Use of Opioids for the Treatment of Chronic Pain*
&NA; (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199703000-00003 · Cited by 208
Research works printed but not linked: 1
- Gijbels, 1998, Neuromodulation of pain. A consensus statement of the European Federation of IASP Chapters (EFIC)., Eur J Pain, 2, 203
Cited by
Items 101–200 of 494
Opioid-Induced Hypogonadism: Why and How to Treat It
Aloisi, A. M. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es111 · Cited by 54
Rhyu, M., Lu, J. H., Webster, D. E., Fabricant, D. S., Farnsworth, N. R., & Wang, Z. J. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062808u · Cited by 76
Johnson, J. L., Hutchinson, M. R., Williams, D. B., & Rolan, P. E. (2012) · Cephalalgia · doi:10.1177/0333102412467512 · Cited by 68
Ziconotide Monotherapy: A Systematic Review of Randomised Controlled Trials
Brookes, M. E., Eldabe, S. S., & Batterham, A. M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160210142056 · Cited by 65
Long‐term opioid therapy in Denmark: A disappointing journey
Birke, H., Ekholm, O., Sjøgren, P., Kurita, G. P., & Højsted, J. (2017) · European Journal of Pain · doi:10.1002/ejp.1053 · Cited by 66
KotliÅ„ska-Lemieszek, A., & Zylicz, Z. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s342409 · Cited by 74
Intrathecal Drug Administration in Chronic Pain Syndromes
Donck, A. V., Vranken, J. H., Puylaert, M., Hayek, S. M., Mekhail, N. A., & Zundert, J. H. M. V. (2013) · Pain Practice · doi:10.1111/papr.12111 · Cited by 63
Rubinstein, A. L., Carpenter, D. M., & Minkoff, J. R. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31827c7b5d · Cited by 62
MECHANISMS OF ENDOCRINOLOGY: endocrinology of opioids
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0270 · Cited by 60
Chronic opioid therapy in long-term cancer survivors
Carmona‐Bayonas, A., Jiménez‐Fonseca, P., Castañón, E., Vaswani, A. R., Sánchez-Bayona, R., Custodio, A. B., Calvo-Temprano, D., & Virizuela, J. A. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1529-6 · Cited by 63
Opioids for Chronic Nonterminal Pain
Ballantyne, J. C. (2006) · Southern Medical Journal · doi:10.1097/01.smj.0000223946.19256.17 · Cited by 66
Male fertility as a marker for health
Chen, T., Belladelli, F., Giudice, F. D., & Eisenberg, M. L. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.09.023 · Cited by 63
Clinical Uses of Intrathecal Therapy and Its Placement in the Pain Care Algorithm
Pope, J. E., Deer, T. R., Bruel, B. M., & Falowski, S. M. (2016) · Pain Practice · doi:10.1111/papr.12438 · Cited by 60
Hypogonadism in male cancer patients
Burney, B. O., & Garcia, J. M. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-012-0065-7 · Cited by 53
Opioid Therapy in Chronic Pain
Ballantyne, J. C. (2015) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2014.12.001 · Cited by 60
Opioids in chronic noncancer pain
Manchikanti, L., Benyamin, R. M., Datta, S., Vallejo, R., & Smith, H. S. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.37 · Cited by 65
Grecco, G. G., Mork, B. E., Huang, J.-Y., Metzger, C. E., Haggerty, D. L., Reeves, K. C., Gao, Y., Hoffman, H., Katner, S. N., Masters, A. R., et al. (2021) · eLife · doi:10.7554/elife.66230 · Cited by 61
Duarte, R. V., Raphael, J. H., Southall, J. L., Labib, M. H., Whallett, A. J., & Ashford, R. L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002856 · Cited by 55
Opioids in chronic non-cancer pain
Chan, B. K. B., Tam, L. K., Wat, C. Y., Chung, Y. F., Tsui, S. L., & Cheung, C. W. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.536335 · Cited by 58
Elucidating risk factors for androgen deficiency associated with daily opioid use
Rubinstein, A., & Carpenter, D. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.015 · Cited by 53
Aloisi, A. M., Ceccarelli, I., Fiorenzani, P., Maddalena, M., Rossi, A., Tomei, V., Sorda, G., Danielli, B., Rovini, M., Cappelli, A., et al. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-69 · Cited by 58
Adrenal insufficiency in patients on long-term opioid analgesia
Gibb, F. W., Stewart, A., Walker, B. R., & Strachan, M. W. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.13125 · Cited by 52
Lamprecht, A., Sorbello, J., Jang, C., Torpy, D. J., & Inder, W. J. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0530 · Cited by 52
Sex-related influences on pain: A review of mechanisms and clinical implications.
Fillingim, R. B. (2003) · Rehabilitation Psychology · doi:10.1037/0090-5550.48.3.165 · Cited by 58
Ellis, D., Dissanayake, S., McGuire, D., Charapata, S. G., Staats, P. S., Wallace, M. S., Grove, G. W., & Vercruysse, P. (2008) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1525-1403.2007.00141.x · Cited by 52
Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids
Li, T., Cunningham, J. L., Gilliam, W. P., Loukianova, L., Donegan, D. M., & Bancos, I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa499 · Cited by 51
Intrathecal Therapy: What Has Changed With the Introduction of Ziconotide
Kress, H. G., Simpson, K. H., Marchettini, P., Donck, A. V., & Varrassi, G. (2009) · Pain Practice · doi:10.1111/j.1533-2500.2009.00308.x · Cited by 50
Safety concerns with long-term opioid use
Harned, M. E., & Sloan, P. A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1177509 · Cited by 55
White, H. D., Brown, L. A. J., Gyurik, R. J., Manganiello, P. D., Robinson, T. D., Hallock, L. S., Lewis, L. D., & Yeo, K.-T. J. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.05.016 · Cited by 48
Webster, L. R. (2015) · Pain Medicine · doi:10.1111/pme.12666 · Cited by 48
Methadone treatment of chronic non‐malignant pain and opioid dependence — A long‐term follow‐up
Rhodin, A., Grönbladh, L., Nilsson, L. ‐., & Gordh, T. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.05.003 · Cited by 48
Adrenocortical Stress Response during the Course of Critical Illness
Peeters, B., Langouche, L., & Van den Berghe, G. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170022 · Cited by 39
Overcoming delivery barriers in immunotherapy for glioblastoma
Rui, Y., & Green, J. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01008-2 · Cited by 47
Blick, G., Khera, M., Bhattacharya, R. K., Nguyen, D., Kushner, H., & Miner, M. M. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01368.x · Cited by 45
Bloodworth, D. (2005) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000154907.30010.1b · Cited by 49
Gupta, P., Gaines, N., Sirls, L. T., II, & Peters, K. M. (2015) · PubMed Central · doi:10.3978/j.issn.2223-4683.2015.10.10 · Cited by 48
Opioid-Induced Androgen Deficiency (OPIAD): Diagnosis, Management, and Literature Review
O’Rourke, T. K., & Wosnitzer, M. S. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0634-y · Cited by 45
Long-term Intrathecal Drug Administration for Chronic Nonmalignant Pain
Duarte, R. V., Raphael, J. H., Sparkes, E., Southall, J. L., LeMarchand, K., & Ashford, R. L. (2011) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e31822ff779 · Cited by 44
Pain management in cancer survivorship
Kurita, G. P., & Sjøgren, P. (2015) · Acta Oncologica · doi:10.3109/0284186x.2014.996662 · Cited by 43
Secondary Adrenal Insufficiency: Recent Updates and New Directions for Diagnosis and Management
Gruber, L., & Bancos, I. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.09.011 · Cited by 45
Nakamura, M., Fujimura, T., Nagata, M., Hosoda, C., Suzuki, M., Fukuhara, H., Enomoto, Y., Nishimatsu, H., Kume, H., Igawa, Y., et al. (2012) · The Aging Male · doi:10.3109/13685538.2011.646342 · Cited by 42
Pain Medications and Male Reproduction
Drobnis, E. Z., & Nangia, A. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-69535-8_6 · Cited by 42
Dominguez, E., Sahinler, B. E., Bassam, D., Day, M. R., Lou, L., Racz, G. B., & Raj, P. P. (2002) · Pain Practice · doi:10.1046/j.1533-2500.2002.02040.x · Cited by 42
Brogan, S. E., Sindt, J. E., Jackman, C., White, J. R., Wilding, V., & Okifuji, A. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004276 · Cited by 40
Chevlen, E. M. (2003) · Current Pain and Headache Reports · doi:10.1007/s11916-003-0005-5 · Cited by 40
Low Back Pain: From Algorithm to Cost‐Effectiveness?
Zundert, J. H. M. V., & van Kleef, M. (2005) · Pain Practice · doi:10.1111/j.1533-2500.2005.05303.x · Cited by 40
Negus, S. S., Zuzga, D. S., & Mello, N. K. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.124734 · Cited by 39
Functional hypothalamic and drug-induced amenorrhea: an overview
Lania, A. G., Gianotti, L., Gagliardi, I., Bondanelli, M., Vena, W., & Ambrosio, M. R. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01013-w · Cited by 42
Tramadol-induced adrenal insufficiency
Debono, M., Chan, S., Rolfe, C., & Jones, T. H. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-0992-9 · Cited by 40
Opioid‐induced hypogonadism: Pathophysiology, clinical and therapeutics review
Antony, T., Alzaharani, S. Y., & El-Ghaiesh, S. H. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13246 · Cited by 40
Baykara, S., & Alban, K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.153 · Cited by 38
Valverde-Filho, J., Cunha Neto, M. B. C. D., Fonoff, E. T., Meirelles, E. D. S., & Teixeira, M. J. (2015) · Pain Medicine · doi:10.1111/pme.12661 · Cited by 37
Changes in metabolic-related variables during chronic morphine treatment
Ferenczi, S., Núñez, C., Pintér-Kübler, B., Földes, A., Martín‐Sánchez, F., Márkus, V. L., Milanés, M. V., & Kovács, K. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.011 · Cited by 37
Intrathecal Drug Delivery System (IDDS) for Cancer Pain Management: A Review and Updates
Upadhyay, S. P., & Mallick, P. N. (2011) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909111426134 · Cited by 41
Opioid effectiveness and side effects in chronic pain
Christo, P. J. (2003) · Anesthesiology Clinics of North America · doi:10.1016/s0889-8537(03)00087-7 · Cited by 41
Opioid Abuse as Maladaptive Coping to Life Stressors in U.S. Adults
Hendy, H. M., Black, P., Can, S. H., Fleischut, A., & Aksen, D. E. (2018) · Journal of Drug Issues · doi:10.1177/0022042618783454 · Cited by 36
Methadone-Induced Hypoglycemia
Faskowitz, A. J., Kramskiy, V. N., & Pasternak, G. W. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9919-6 · Cited by 36
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
Demarest, S. P., Gill, R. S., & Adler, R. A. (2014) · Endocrine Practice · doi:10.4158/ep14339.ra · Cited by 35
Opioids for chronic noncancer pain
McCleane, G. J. (2009) · Therapy · doi:10.2217/thy.09.49 · Cited by 35
Deer, T. R., Hayek, S. M., Grider, J. S., Pope, J. E., Brogan, S. E., Gulati, A., Hagedorn, J. M., Strand, N. H., Hah, J. M., Yaksh, T. L., et al. (2024) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2024.08.006 · Cited by 33
Vissers, K. C. P., Besse, K., Wagemans, M., Zuurmond, W. W. A., Giezeman, M. J. M. M., Lataster, A., Mekhail, N. A., Burton, A. W., van Kleef, M., & Huygen, F. J. P. M. (2011) · Wiley eBooks · doi:10.1002/9781119968375.ch23 · Cited by 33
Gerritsen, R., Soede, N. M., Langendijk, P., Dieleman, S. J., Hazeleger, W., & Kemp, B. (2007) · Reproduction in Domestic Animals · doi:10.1111/j.1439-0531.2007.00843.x · Cited by 33
Physiological Mechanisms Integrating Metabolism and Reproduction
Krasnow, S. M., & Steiner, R. D. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50052-x · Cited by 36
Nenke, M. A., Haylock, C. L., Rankin, W., Inder, W. J., Gagliardi, L., Eldridge, C., Rolan, P., & Torpy, D. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.03.015 · Cited by 32
Opioid endocrinopathy: a clinical problem in patients with cancer pain
MERDIN, A., MERDIN, F. A., GÜNDÜZ, Ş., BOZCUK, H., & COŞKUN, H. Ş. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3156 · Cited by 32
Richardson, E., Bedson, J., Chen, Y., Lacey, R. J., & Dunn, K. M. (2018) · European Journal of Pain · doi:10.1002/ejp.1256 · Cited by 35
Katz, N. P., & Benoit, C. M. (2005) · Current Pain and Headache Reports · doi:10.1007/s11916-005-0056-x · Cited by 33
Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia
Lee, A. S., & Twigg, S. M. (2015) · Endocrinology, Diabetes & Metabolism Case Reports · doi:10.1530/edm-15-0035 · Cited by 31
Kosorukov, V. S., Abuzarova, G. R., Ревовна, З. Е., Gamzeleva, O. Y., & Yatsenko, K. A. (2022) · Head and neck tumors (HNT) · doi:10.17650/2222-1468-2022-12-2-89-107 · Cited by 33
Lutz, M. C., Roberts, R. O., Jacobson, D. J., McGree, M. E., Lieber, M. M., & Jacobsen, S. J. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000165386.26542.23 · Cited by 31
Drug-induced HPA axis alterations during acute critical illness: a multivariable association study
Peeters, B., Güiza, F., Boonen, E., Meersseman, P., Langouche, L., & Van den Berghe, G. (2017) · Clinical Endocrinology · doi:10.1111/cen.13155 · Cited by 31
Vázquez-Borrego, M. C., Gahete, M. D., Martínez‐Fuentes, A. J., Fuentes-Fayos, A. C., Castano, J. P., Kineman, R. D., & Luque, R. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.12.007 · Cited by 35
Opioids Increase Sexual Dysfunction in Patients with Non-Cancer Pain
Ajo, R., Segura, A., Inda, M., Planelles, B., Martínez, L. L., Ferrández, G., Sánchez, A., Margarit, C., & Peiró, A. M. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.07.003 · Cited by 35
Barbosa, J., Faria, J., Garcez, F., Leal, S. M., Afonso, L. P., Nascimento, A. V., Moreira, R. F., Queirós, O., Carvalho, F. D., & Dinis‐Oliveira, R. J. (2020) · Pharmaceuticals · doi:10.3390/ph13070149 · Cited by 34
Socially induced morphine pseudosensitization in adolescent mice
Hodgson, S. R., Hofford, R. S., Roberts, K. W., Wellman, P. J., & Eitan, S. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328337be25 · Cited by 27
Central causes of hypogonadism—functional and organic
Warren, M. P., & Vu, C. Q. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00042-2 · Cited by 30
Powers, A. D., Madan, A., Hilbert, M. L. T., Reeves, S. T., George, M. S., Nash, M. R., & Borckardt, J. J. (2017) · Pain Medicine · doi:10.1093/pm/pnx098 · Cited by 30
Opioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Clinical presentation and outcomes of opioid-induced adrenal insufficiency
Li, T., Donegan, D., Hooten, W. M., & Bancos, I. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0297 · Cited by 27
Effect of Opioids on Testosterone Levels: Cross-Sectional Study using NHANES
Cepeda, M. S., Zhu, V. J., Vorsanger, G., & Eichenbaum, G. M. (2015) · Pain Medicine · doi:10.1111/pme.12843 · Cited by 27
Moghaddam, M. G., Khalili, M., Maleki, M., & Abadi, M. E. A. (2013) · PubMed Central · Cited by 27
Ajo, R., Segura, A., Mira, L., Inda, M., Alfayate, R., Sánchez-Barbie, Á., Margarit, C., & Peiró, A. M. (2016) · The Aging Male · doi:10.1080/13685538.2016.1185408 · Cited by 28
Cancer‐related fatigue: Evolving concepts in evaluation and treatment
Daniell, H. (2004) · Cancer · doi:10.1002/cncr.20246 · Cited by 27
Wisniewski, A. B., Brown, T. T., John, M., Frankowicz, J. K., Cofranceso, J., Golub, E. T., Ricketts, E. P., & Dobs, A. S. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80007-6 · Cited by 27
Opioids for Persistent Noncancer Pain
McCleane, G. J., & Smith, H. S. (2007) · Anesthesiology Clinics · doi:10.1016/j.anclin.2007.08.002 · Cited by 26
Amini, H., & Ahmadiani, A. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.07.001 · Cited by 26
Impact of morphine dependency and detoxification by methadone on male's rat reproductive system.
Ghowsi, M., & Yousofvand, N. (2015) · PubMed · Cited by 25
Intrathecal Morphine Infusion for Chronic Non-Malignant Pain: A Multiple Center Retrospective Survey
Njee, T., Irthum, B., Roussel, P., & Peragut, J. C. (2004) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1094-7159.2004.04210.x · Cited by 25
Intrathecal Opioid Therapy for Non-Malignant Chronic Pain: A Long-Term Perspective
Kleinmann, B., & Wolter, T. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12617 · Cited by 25
Low-Serum Cortisol Associated With Opioid Use: Case Report and Review of the Literature
Lee, C. Y. W., Ludwig, S. M., & Duerksen, D. R. (2002) · The Endocrinologist · doi:10.1097/00019616-200201000-00002 · Cited by 27
New opioid side effects and implications for long-term therapy
Raghavan, S., Harvey, A., & Humble, S. R. (2010) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.cacc.2010.06.003 · Cited by 31
The effects of opioids on the endocrine system: an overview
Ali, K., Raphael, J., Khan, S., Labib, M., & Duarte, R. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134299 · Cited by 24
Pituitary side effects of old and new drugs
Zatelli, M. C., Ambrosio, M. R., Bondanelli, M., & Uberti, E. C. D. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0133-2 · Cited by 24
Seeber, B., Böttcher, B., D’Costa, E., & Wildt, L. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.07.001 · Cited by 26
The Direct and Indirect Costs among U.S. Privately Insured Employees with Hypogonadism
Kaltenboeck, A., Foster, S. A., Ivanova, J. I., Diener, M. D., Bergman, R., Birnbaum, H. G., Kinchen, K., & Swindle, R. W. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02810.x · Cited by 25
Duarte, R. V., Raphael, J. H., Labib, M., Southall, J. L., & Ashford, R. L. (2013) · Pain Physician · doi:10.36076/ppj.2013/16/9 · Cited by 24
Long-term Opioids Linked to Hypogonadism and the Role of Testosterone Supplementation Therapy
Marudhai, S., Patel, M., Subas, S. V., Ghani, M. R., Busa, V., Dardeir, A., & Cancarevic, I. (2020) · Cureus · doi:10.7759/cureus.10813 · Cited by 29
From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks
Jaschke, N., Pählig, S., Pan, Y., Hofbauer, L. C., Göbel, A., & Rachner, T. D. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.004 · Cited by 24
Reproduction as a window for health in men
Belladelli, F., Muncey, W. W., & Eisenberg, M. L. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.014 · Cited by 25
Metadata
- Authors
- Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K.
- Affiliations
- Antwerp University Hospital (BE)
- Maria Middelares Hospital St. Niklaas (J.-P.V.B.), B-2650 Edegem, Belgium
- ZNA Middelheim Hospital (BE)
- Department of Neurosurgery, University Hospital Antwerp (J.V., T.V.H.), B-2650 Edegem, Belgium
- Department of Endocrinology, University Hospital Antwerp (R.A., K.V.A.), B-2650 Edegem, Belgium
- ORCID
- Smet, Mike
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-06-01
- Volume
- 85
- Issue
- 6
- Pages
- 2215-2222
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2135470636
- Cited by
- 491
- References
- 33
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 16 · 2023: 14 · 2022: 22 · 2021: 20 · 2020: 17 · 2019: 23 · 2018: 23 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 20 · 2013: 26 · 2012: 32
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- intrathecal opioids, morphine, hypothalamic-pituitary function, testosterone, free androgen index, luteinizing hormone, follicle-stimulating hormone, amenorrhea, menstrual cycle, sexual desire, erectile dysfunction, urinary free cortisol, insulin-induced hypoglycemia, cortisol response, hypothalamic-pituitary-adrenal axis, chronic non-cancer pain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Amenorrhea, Analgesics, Opioid, Androgens, Blood Pressure, Hydromorphone, Estradiol, Female, Follicle Stimulating Hormone, Hormones, Humans, Hydrocortisone, Erectile Dysfunction, Injections, Spinal, Luteinizing Hormone, Libido, Male, Middle Aged, Morphine, Pain, Intractable, Intractable Pain, Progesterone, Reference Values, Retrospective Studies, Sex Hormone-Binding Globulin, Premenopause, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.